FilingsTodayMiwon Chemicals
At a glance
Miwon Chemicals filed 65 disclosures in the last 12 months, including 22 insider, 7 5% holder and 3 buyback. The most recent key filing was on Oct 1.
Revenue for 2025 was ₩285B, up 11.1% on 2024. Operating margin was 10.2% against 11.2% a year earlier. Debt was 13% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩192B and operating profit of ₩33.4B.
The 2025 annual report lists 235 employees with an average tenure of 9 years and average pay of ₩77.9M, #418 of 1,829 listed companies by average pay. Its 7 directors and auditors were paid ₩191M each on average. It paid ₩4,500 per common share in cash dividends, against ₩4,000 a year earlier (+12.5%). 김정돈 and related parties held 55.24% at year end.
From the 2025 annual report
Staff: 235 (197 men, 38 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩18.1B. Directors and auditors: 7, paid ₩1.3B in total.
Dividends (common shares)
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash dividend per share | ₩4,500 | ₩4,000 | ₩3,500 |
| Payout ratio | 29.8% | 29.8% | 32.4% |
| Yield (as filed) | 4.76% | 5.03% | 4.99% |
| Total cash dividends | ₩8.9B | ₩8B | ₩7.1B |
Largest shareholder
김정돈 holds 3.18%; with 38 related parties the group holds 55.24% of common shares at year end (from 56.58% at the start of the year).
Auditor: 우리회계법인 · opinion: Unqualified.
Rankings: Low debt #55 of 1,372
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
Other filings
Links open the original filing on DART, in Korean.